221 related articles for article (PubMed ID: 38283750)
1. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
2. Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Guo W; Lin Y; Hu S; Shen Y
Clin Ther; 2023 Oct; 45(10):973-976. PubMed ID: 37599165
[TBL] [Abstract][Full Text] [Related]
3. A controlled clinical trial comparing potent progestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis.
Ota I; Taniguchi F; Ota Y; Nagata H; Wada I; Nakaso T; Ikebuchi A; Sato E; Azuma Y; Harada T
Reprod Med Biol; 2021 Oct; 20(4):427-434. PubMed ID: 34646070
[TBL] [Abstract][Full Text] [Related]
4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis.
Yang S; Liu Y; Wen J; Sun Y; Ren F
Evid Based Complement Alternat Med; 2022; 2022():1995472. PubMed ID: 35873621
[TBL] [Abstract][Full Text] [Related]
7. Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
Harada T; Ota I; Kitawaki J; Momoeda M; Maeda N; Akira S; Umeyama M; Sunaya T; Hirano K
Contraception; 2022 Dec; 116():22-28. PubMed ID: 36057322
[TBL] [Abstract][Full Text] [Related]
8. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.
Gupta JK; Daniels JP; Middleton LJ; Pattison HM; Prileszky G; Roberts TE; Sanghera S; Barton P; Gray R; Kai J;
Health Technol Assess; 2015 Oct; 19(88):i-xxv, 1-118. PubMed ID: 26507206
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
11. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Sangkomkamhang US; Lumbiganon P; Pattanittum P
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
[TBL] [Abstract][Full Text] [Related]
12. Surgery versus medical therapy for heavy menstrual bleeding.
Marjoribanks J; Lethaby A; Farquhar C
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003855. PubMed ID: 26820670
[TBL] [Abstract][Full Text] [Related]
13. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
[TBL] [Abstract][Full Text] [Related]
14. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract][Full Text] [Related]
16. Combined hormonal contraceptives for heavy menstrual bleeding.
Lethaby A; Wise MR; Weterings MA; Bofill Rodriguez M; Brown J
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD000154. PubMed ID: 30742315
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
Calaf J; Lete I; Canals I; Crespo C; Espinós B; Cristóbal I
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():24-31. PubMed ID: 25462215
[TBL] [Abstract][Full Text] [Related]
18. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
[TBL] [Abstract][Full Text] [Related]
19. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
20. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
Kelekci S; Kelekci KH; Yilmaz B
Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]